SARS-CoV-2 initiates programmed cell death in platelets
M Koupenova, HA Corkrey, O Vitseva… - Circulation …, 2021 - Am Heart Assoc
Rationale: Coronavirus disease 2019 (COVID-19) is characterized by increased incidence
of microthrombosis with hyperactive platelets sporadically containing viral RNA. It is unclear …
of microthrombosis with hyperactive platelets sporadically containing viral RNA. It is unclear …
SARS-CoV-2 initiates programmed cell death in platelets.
M Koupenova, HA Corkrey, O Vitseva, K Tanriverdi… - 2021 - cabidigitallibrary.org
Abstract Rationale: Coronavirus disease 2019 (COVID-19) is characterized by increased
incidence of microthrombosis with hyperactive platelets sporadically containing viral RNA. It …
incidence of microthrombosis with hyperactive platelets sporadically containing viral RNA. It …
SARS-CoV-2 Initiates Programmed Cell Death in Platelets
M Koupenova, HA Corkrey, O Vitseva… - Circulation …, 2021 - ingentaconnect.com
Rationale: Coronavirus disease 2019 (COVID-19) is characterized by increased incidence
of microthrombosis with hyperactive platelets sporadically containing viral RNA. It is unclear …
of microthrombosis with hyperactive platelets sporadically containing viral RNA. It is unclear …
SARS-CoV-2 Initiates Programmed Cell Death in Platelets.
M Koupenova, HA Corkrey, O Vitseva… - Circulation …, 2021 - europepmc.org
Objective: To characterize the direct SARS-CoV-2–platelet interactions using in vitro studies
with purified infectious virions and samples from infected patients. Methods and Results …
with purified infectious virions and samples from infected patients. Methods and Results …
[PDF][PDF] SARS-CoV-2 Initiates Programmed Cell Death in Platelets
M Koupenova, HA Corkrey, O Vitseva… - Circulation …, 2021 - researchgate.net
OBJECTIVE: To characterize the direct SARS-CoV-2–platelet interactions using in vitro
studies with purified infectious virions and samples from infected patients. METHODS AND …
studies with purified infectious virions and samples from infected patients. METHODS AND …
SARS-CoV-2 Initiates Programmed Cell Death in Platelets
M Koupenova, HA Corkrey, O Vitseva, K Tanriverdi… - Circulation …, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Rationale:</jats: title>< jats: p> Coronavirus disease 2019
(COVID-19) is characterized by increased incidence of microthrombosis with hyperactive …
(COVID-19) is characterized by increased incidence of microthrombosis with hyperactive …
SARS-CoV-2 Initiates Programmed Cell Death in Platelets
M Koupenova, HA Corkrey, O Vitseva… - Circulation …, 2021 - pubmed.ncbi.nlm.nih.gov
SARS-CoV-2 Initiates Programmed Cell Death in Platelets SARS-CoV-2 Initiates Programmed
Cell Death in Platelets Circ Res. 2021 Sep 3;129(6):631-646. doi: 10.1161/CIRCRESAHA.121.319117 …
Cell Death in Platelets Circ Res. 2021 Sep 3;129(6):631-646. doi: 10.1161/CIRCRESAHA.121.319117 …
[HTML][HTML] SARS-CoV-2 Initiates Programmed Cell Death in Platelets
M Koupenova, HA Corkrey, O Vitseva… - Circulation …, 2021 - Am Heart Assoc
Objective: To characterize the direct SARS-CoV-2–platelet interactions using in vitro studies
with purified infectious virions and samples from infected patients. Methods and Results …
with purified infectious virions and samples from infected patients. Methods and Results …
[HTML][HTML] SARS-CoV-2 Initiates Programmed Cell Death in Platelets
M Koupenova, HA Corkrey, O Vitseva… - Circulation …, 2021 - ncbi.nlm.nih.gov
OBJECTIVE: To characterize the direct SARS-CoV-2–platelet interactions using in vitro
studies with purified infectious virions and samples from infected patients. METHODS AND …
studies with purified infectious virions and samples from infected patients. METHODS AND …
[HTML][HTML] SARS-CoV-2 Initiates Programmed Cell Death in Platelets
M Koupenova, HA Corkrey, O Vitseva… - Circulation …, 2021 - ncbi.nlm.nih.gov
Objective: To characterize the direct SARS-CoV-2-platelet interactions using in vitro studies
with purified infectious virions and samples from infected patients. Methods and Results …
with purified infectious virions and samples from infected patients. Methods and Results …